In situ synthesis of DNA microarray on functionalized cyclic

[…] both prone to error and relatively slow. For example, today’s DNA synthesis lets us write a few hundred bytes per second; a modern hard drive can write hundreds of millions of bytes per second. An average iPhone photo […]

Solvent resistant microfluidic DNA synthesizer.

Electrochemically directed synthesis of oligonucleotides for DNA microarray

Order of magnitude cost reduction without array synthesis

By forming alliances with Dentsu Group clients and partner companies, Dentsu Ventures will support Twist Bioscience's innovative business development.

Profiles of Twist Bioscience and Dentsu Ventures are provided below.

Profile of Twist Bioscience
Company Name: Twist Bioscience Corporation
Location: San Francisco, California, U.S.A.
Representative: Emily LeProust (CEO)
Line of Business: Providing High-Throughput DNA Synthesis for Multiple Industries

Profile of Dentsu Ventures
Name: Dentsu Ventures Global Fund I
Total Fund Capital: 10.0 billion yen
Date of Establishment: April 2015
Period of Operation: Slated for 10-year period, through March 2025
Investment Regions: Global investments with a focus on the U.S., Europe Japan and Asia
Investment Stages: Balanced, wide-ranging investments with the focus on seed and early stage investments, but also including mid-stage and later-stage investments
Investment Areas:
(1) Areas that can change the marketing and communication business in a broad sense
(2) New areas other than the above that have a high potential for innovation


DNA synthesis companies: cost per base, turn-around …

The second important thing to notice about these plots is that I have changed the name of the metric from “cost” to “price”. Previously, I had decided that this distinction amounted to no real difference for my purposes. Now, however, the world has changed, and cost and price are very different concepts for anyone thinking about the future of DNA. Previously, there was at times an order of magnitude change in cost from year to year, and keeping track of the difference between cost and price didn’t matter. In a period when change is much slower, that difference becomes much more important. Moreover, as the industry becomes larger, more established, and generally more important for the economy, we should all take more care in distinguishing between concepts like cost and price .

AGene synthesis is the process of chemically synthesizing double-stranded DNA molecules in vitro.
MilliGen/Biosearch Cyclone Plus DNA synthesizer 05076Discription of ListingCyclone Plus DNA synthesizerImage Item ID ...

Gen9 Announces Lower-Cost DNA Synthesis, Seeks ..

Synbio Technologies is one of the leading companies in industry, especially with respect to gene synthesis. We have developed the only complete platform in the world with the to meet our customer’s needs in flux, delivery cycle, pricing, synthesis difficulty and other various dimensions. We are proud of being the only company within this industry to develop such a platform, and have the upmost reliability in this technology. This reliability and efficiency is seen in our production each month, resulting in the synthesis of over 2 million base pairs of DNA sequences including genes, genomes, and other various biological pathways. The resulting products are then delivered globally to our customers within an efficient timeframe.

This approach achieves breakthrough increases in efficiency, speed and quality of DNA production, compared with conventional DNA synthesis processes.

down the cost of DNA synthesis without ..

Twist Bioscience is a privately-held venture-backed company. The two key investors are ARCH Venture Partners and Paladin Capital Group. The founders of Twist Bioscience are proven entrepreneurs and innovators in the genomics field. Our expertise is synthetic DNA. We have developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis and genomes. By synthesizing DNA on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic DNA production, and enables cost-effective, rapid, high-quality and high throughput synthetic gene production. The Twist Bioscience platform has the potential to greatly accelerate the development of personalized medicine, sustainable chemical production, improved agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. For more information, please visit . Twist Bioscience is on Twitter. Sign up to follow our Twitter feed @TwistBioscience at .

Artificial gene synthesis is the chemical synthesis of a DNA sequence that represents one or more genes.

Scalable gene synthesis by selective amplification of DNA pools

[…] both prone to error and relatively slow. For example, today’s DNA synthesis lets us write a few hundred bytes per second; a modern hard drive can write hundreds of millions of bytes per second. An average iPhone photo […]